Globus Medical GMED Cash Flow Statement (2011-2026)

NYSE GMED
$74.13 -0.39 (-0.52%)
As of: Sep 10, 2026 · 12:37 PM EDT
Reported Financials

Globus Medical Quarterly Cash Flow Statement

Periods 60 quarters
Latest Jun 2026

Globus Medical reported cash from operations of $209.74M and free cash flow of $176.57M for the quarter ended Jun 2026, up 169.4% year over year. This cash flow statement covers 60 quarters of results from Jun 2011 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
47.21M1.87M38.08M54.59M47.43M31.98M49.13M57.71M1.00M15.03M-7.16M31.76M51.84M26.50M75.46M202.85M118.97M140.59M124.30M151.57M
Share-based CompensationStock Comp.
66.10M7.80M10.48M68.80M78.80M8.51M11.30M85.30M106.30M17.26M109.50M96.20M11.91M13.21M118.50M108.60M11.42M12.62M13.38M
Deferred Taxes
-1.35M-14.48M-2.99M-4.95M-9.07M-5.21M-3.98M-7.18M-34.83M-11.80M-45.09M-20.18M-27.45M-33.18M0.51M-41.74M41.76M18.10M7.96M7.79M
Gains from Investment SecuritiesGains Investment
0.21M2.47M-0.26M-1.13M-0.65M7.17M-0.45M3.73M1.15M13.00M-0.17M12.90M-4.13M17.91M0.17M5.22M-2.72M10.79M6.35M9.71M
Asset Writedowns and ImpairmentWritedown
0.57M0.57M1.83M2.23M1.82M0.51M2.06M1.92M2.73M4.26M3.91M7.57M4.71M7.17M5.96M4.97M5.05M6.13M5.28M5.12M
Cash from OperationsCash from Ops.
77.26M76.25M44.69M36.88M32.92M63.98M53.31M35.03M50.48M104.67M52.39M54.26M203.65M210.34M177.30M77.86M249.69M248.59M202.36M209.74M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
52.59M53.67M53.67M60.76M47.32M0.05M6.00M6.96M
Depreciation & Amortization (CF)Dep. & Amort.
16.75M16.83M16.84M16.93M17.58M16.91M18.11M18.07M37.39M71.95M55.26M63.59M66.95M67.59M65.65M70.63M71.55M69.01M69.86M69.50M
Change in Working Capital
Change in ReceivablesChange Receivables
-5.66M5.97M1.61M28.61M15.98M4.64M9.86M18.38M8.72M12.96M36.39M87.81M-23.66M-22.48M-22.60M2.21M8.42M64.15M13.40M13.81M
Change in InventoryChange Inventory
3.14M2.81M17.94M13.48M17.23M13.10M22.47M16.19M20.32M11.35M8.99M13.87M-4.88M11.89M7.59M4.13M5.70M0.18M16.65M27.90M
Change in Account PayablesChange Payables
-0.22M1.16M4.16M8.21M-1.97M4.01M3.92M-6.68M-5.18M-6.27M-5.75M17.31M-10.27M16.37M-0.90M-3.19M3.43M9.14M5.08M0.31M
Change in Accured ExpensesChange Accured Exp.
3.94M10.40M-15.43M8.02M9.07M4.43M-9.97M9.08M21.47M-3.45M-33.88M4.93M29.34M4.63M-28.66M14.82M39.28M8.78M-24.67M-11.07M
Change in TaxesChange Taxes
0.69M15.04M12.98M-14.94M1.25M-2.18M16.44M-13.39M10.34M-13.79M40.52M-33.74M-11.65M-8.50M19.61M-58.23M-19.31M7.08M14.58M4.81M
Investing Activities
Capital ExpendituresCapex
17.80M17.05M19.97M23.75M11.98M18.34M15.99M17.87M21.53M22.88M28.57M27.80M41.95M17.11M36.10M46.56M35.82M46.20M39.62M33.17M
Sales of Property, Plant and EquipmentPP&E (Sale)
Acquisitions
1.00M0.17M30.26M2.66M293.37M12.65M4.89M0.10M5.00M252.55M-5.00M4.91M1.50M
Change in Acquisitions & DivestmentsChange Acquisitions
40.15M56.02M106.55M64.02M68.55M73.09M85.55M73.78M60.66M317.74M2.56M19.14M26.04M10.92M174.24M-58.63M8.24M13.24M
Cash from Investing ActivitiesCash from Investing
-6.88M-243.80M-13.89M27.13M-63.11M-60.48M10.99M52.22M-80.86M320.62M-46.58M-10.38M-14.97M-104.12M131.38M-299.11M-75.84M-111.45M-182.67M-129.05M
Financing Activities
Other financing activitiesOther financing
24.34M3.56M7.75M3.58M14.90M15.49M4.86M3.20M3.30M1.04M3.41M14.24M23.50M69.28M11.22M4.70M11.08M62.76M25.96M10.97M
Cash from Financing ActivitiesCash from Financing
22.68M-1.02M6.05M-142.76M13.16M13.59M2.94M1.08M1.43M-237.27M-115.72M8.71M19.58M59.73M-635.40M-24.94M-32.04M13.21M18.20M-134.50M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
2.16M1.34M2.74M1.20M1.90M1.45M2.79M1.69M
Net Equity Issued and RepurchasedNet Equity Issued
Additional items
Exchange Rate EffectFX Effect
0.04M-0.24M-0.12M-0.26M0.48M-0.84M-0.03M0.43M2.12M-0.35M-3.31M3.77M4.07M-4.28M3.54M14.36M0.51M4.03M-3.09M0.60M
Change in Cash
93.09M-168.81M36.72M-79.02M-16.55M16.24M67.22M88.77M-26.83M187.67M-113.23M56.36M212.34M161.67M-323.17M-231.82M142.32M154.39M34.79M-53.20M
Free Cash FlowFCF
59.47M59.21M24.72M13.13M20.94M45.63M37.32M17.16M28.95M81.79M23.82M26.46M161.70M193.23M141.20M31.30M213.88M202.39M162.75M176.57M
Net Cash FlowNCF
93.06M-168.57M36.84M-78.75M-17.03M17.08M67.25M88.33M-28.95M188.02M-109.92M52.59M208.27M165.95M-326.71M-246.18M141.81M150.35M37.89M-53.80M